HopeStage
Back to all studies
RecruitingNCT07094789

MR-guided focused ultrasound neuromodulation for hard-to-treat depression

About this titleRead the official source — NCT07094789
Device studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 11, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
20
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT07094789
Official title
Show the full official title

Assessment of Safety and Feasibility of Focused Ultrasound Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Treatment-Resistant Depression

Recruitment & locations

Currently recruiting

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies